Following a presentation by RMTC executive director Dionne Benson, the Thoroughbred Owners and Breeders Association has issued a statement pledging support of the uniform medication program.
J. Curtis Linnell was appointed vice president of wagering analysis and operations for the Thoroughbred Racing Protective Bureau at its board meeting Aug. 7 in Saratoga Springs, N.Y.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Racing Medication and Testing Consortium executive director Dionne Benson discussed the implications of a British steroid ban on U.S. horses Aug. 6 during TOBA's annual members meeting.
Churchill Downs Inc. on July 31 became the 24th racetrack entity in the United States to commit to making a contribution to the Racing Medication and Testing Consortium.
The Round Table will provide updates on medication reform efforts in the U.S., a study on equine drug testing and enforcement, an analysis of racing trends and horse inventories, and a report on new fan and owner initiatives.
The Horseracing Testing Laboratory Committee of the Racing Medication and Testing Consortium has approved full accreditation of three laboratories, it announced April 30.
The Racing Medication and Testing Consortium board of directors took several actions March 17 intended to further the process toward the nationwide adoption of uniform medication rules, penalties, and testing.
- By Frank Angst
- Racing, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky
Regulators and racing leaders are taking a close look at facilities such as the Weatherford Compounding Pharmacy in Texas, which offers products with names such as Equine Growth Hormone, Game Changer, and Tourniquet.
The Racing Medication and Testing Consortium's Tactical Research Program was instrumental in the Delaware Thoroughbred Racing Commission's recent prosecution of trainer Donald Roberson.
- By Tom LaMarra
The Racing Medication and Testing Consortium said July 19 its board of directors has approved a model rule on multiple violation penalties and forwarded the suggested change to racing commissioners for consideration.
The University of California-Davis Kenneth L. Maddy Laboratory and HFL Sport Science in Lexington became the first two fully accredited laboratories under the RMTC Laboratory Accreditation program June 11.
- By Tom LaMarra
Racing organizations are moving ahead with plans to implement a points-driven penalty system for equine medication violations.
RMTC Executive Director Dr. Dionne Benson believes data clearly demonstrates the two microgram limit is a workable threshold for horsemen.
The Racing Medication and Testing Consortium has approved minimum withdrawal time recommendations for corticosteroids based on recently completed work partially funded by RMTC.
The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.
Two more national organizations have called on Kentucky to move forward with medication reform regulations shot down by a legislative committee Aug. 27.
Most Popular Stories
- Speedy Moreno Dangerous Again in Woodward
- Santa Anita's Main Track to Reopen Sept. 2
- Sunset Glow Has Experience Edge in Debutante
- Target on Wise Dan for Bernard Baruch Return
- Gains Posted as Doncaster Premier Sale Ends
- Miss Behaviour Cuts Back for Prioress Run
- Kentucky Considers Allowing Salix-Free Races
- Solis Returns to California to Ride Full Time
- Indicators Drop at Ocala August Yearling Sale
- Clearly Now Faces Class Field in Forego